nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromodiphenhydramine—Orphenadrine—GRIN2D—schizophrenia	0.0126	0.0448	CrCbGaD
Bromodiphenhydramine—Cyclopentolate—CHRM1—schizophrenia	0.0117	0.0414	CrCbGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—HTR1A—schizophrenia	0.0103	0.0144	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—HTR2C—schizophrenia	0.00995	0.0139	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD1—schizophrenia	0.00995	0.0139	CbGpPWpGaD
Bromodiphenhydramine—Doxylamine—CHRM1—schizophrenia	0.00983	0.0348	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—FXYD6—schizophrenia	0.00981	0.0137	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD3—schizophrenia	0.00964	0.0134	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD4—schizophrenia	0.00936	0.013	CbGpPWpGaD
Bromodiphenhydramine—Captodiame—DRD3—schizophrenia	0.00921	0.0326	CrCbGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC18A2—schizophrenia	0.00913	0.0127	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR1B—schizophrenia	0.009	0.0125	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—HTR7—schizophrenia	0.00872	0.0121	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD2—schizophrenia	0.00872	0.0121	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR1A—schizophrenia	0.00866	0.0121	CbGpPWpGaD
Bromodiphenhydramine—Orphenadrine—GRIN1—schizophrenia	0.00854	0.0303	CrCbGaD
Bromodiphenhydramine—Amitriptyline—NTRK2—schizophrenia	0.00853	0.0302	CrCbGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC6A1—schizophrenia	0.00841	0.0117	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD1—schizophrenia	0.00837	0.0117	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR2C—schizophrenia	0.00837	0.0117	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD3—schizophrenia	0.0081	0.0113	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—schizophrenia	0.0079	0.011	CbGpPWpGaD
Bromodiphenhydramine—Benzphetamine—SLC18A2—schizophrenia	0.00789	0.028	CrCbGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD4—schizophrenia	0.00787	0.011	CbGpPWpGaD
Bromodiphenhydramine—Captodiame—HTR2C—schizophrenia	0.00773	0.0274	CrCbGaD
Bromodiphenhydramine—Tolterodine—CHRM1—schizophrenia	0.00745	0.0264	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—HTR3A—schizophrenia	0.00744	0.0104	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR7—schizophrenia	0.00733	0.0102	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD2—schizophrenia	0.00733	0.0102	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—schizophrenia	0.00727	0.0101	CbGpPWpGaD
Bromodiphenhydramine—Diphenylpyraline—SLC6A3—schizophrenia	0.00665	0.0236	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC1A1—schizophrenia	0.00663	0.00923	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—DGKI—schizophrenia	0.00636	0.00887	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—HTR6—schizophrenia	0.00634	0.0225	CrCbGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—HTR2A—schizophrenia	0.00611	0.00851	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC17A7—schizophrenia	0.00606	0.00845	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC6A3—schizophrenia	0.00599	0.00834	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKI—schizophrenia	0.00569	0.00793	CbGpPWpGaD
Bromodiphenhydramine—Toremifene—ESR1—schizophrenia	0.00564	0.02	CrCbGaD
Bromodiphenhydramine—Brompheniramine—CHRM1—schizophrenia	0.00554	0.0196	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—GABRB2—schizophrenia	0.00538	0.00749	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—schizophrenia	0.00518	0.00722	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR2A—schizophrenia	0.00513	0.00715	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC1A1—schizophrenia	0.00513	0.00715	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—HTR6—schizophrenia	0.00497	0.0176	CrCbGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC17A7—schizophrenia	0.00469	0.00654	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC18A2—schizophrenia	0.00464	0.00647	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—NTS—schizophrenia	0.0046	0.00641	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—HTR2C—schizophrenia	0.00456	0.0162	CrCbGaD
Bromodiphenhydramine—Toremifene—CYP1A2—schizophrenia	0.00435	0.0154	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC6A1—schizophrenia	0.00427	0.00595	CbGpPWpGaD
Bromodiphenhydramine—Hydroxyzine—CYP2D6—schizophrenia	0.00416	0.0147	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—schizophrenia	0.00412	0.00573	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—HTR6—schizophrenia	0.00387	0.0137	CrCbGaD
Bromodiphenhydramine—Chlorphenamine—SLC6A3—schizophrenia	0.00386	0.0137	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—FXYD6—schizophrenia	0.00386	0.00538	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—HTR6—schizophrenia	0.00384	0.0136	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ATP2A2—schizophrenia	0.00381	0.0053	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—SLC6A4—schizophrenia	0.00378	0.0134	CrCbGaD
Bromodiphenhydramine—Mepyramine—CYP2D6—schizophrenia	0.00377	0.0134	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—CYP1A2—schizophrenia	0.00376	0.0133	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—CHRM1—schizophrenia	0.00375	0.00523	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—HTR1B—schizophrenia	0.00359	0.0127	CrCbGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC18A2—schizophrenia	0.00359	0.005	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—CHRM1—schizophrenia	0.00358	0.0127	CrCbGaD
Bromodiphenhydramine—Tripelennamine—CYP2D6—schizophrenia	0.00349	0.0124	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—GRM5—schizophrenia	0.00349	0.00486	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—CYP1A2—schizophrenia	0.00344	0.0122	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAAR6—schizophrenia	0.00337	0.00469	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM1—schizophrenia	0.00336	0.00467	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—schizophrenia	0.00331	0.0046	CbGpPWpGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—FOS—schizophrenia	0.00329	0.00459	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR6—schizophrenia	0.00328	0.00457	CbGpPWpGaD
Bromodiphenhydramine—Benzphetamine—SLC6A3—schizophrenia	0.00327	0.0116	CrCbGaD
Bromodiphenhydramine—Atomoxetine—SLC6A3—schizophrenia	0.00325	0.0115	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—CCK—schizophrenia	0.00319	0.00444	CbGpPWpGaD
Bromodiphenhydramine—Promazine—CHRM1—schizophrenia	0.00318	0.0113	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—HTR2A—schizophrenia	0.00317	0.0112	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—schizophrenia	0.00312	0.00434	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—CCKAR—schizophrenia	0.00306	0.00426	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—NTS—schizophrenia	0.00305	0.00425	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	0.00304	0.00424	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—HTR2C—schizophrenia	0.00293	0.0104	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—HTR3A—schizophrenia	0.00292	0.00407	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—HTR2A—schizophrenia	0.0029	0.0103	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—CYP2D6—schizophrenia	0.0029	0.0103	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM1—schizophrenia	0.0029	0.00404	CbGpPWpGaD
Bromodiphenhydramine—Chlorphenamine—SLC6A4—schizophrenia	0.00289	0.0102	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—schizophrenia	0.00285	0.00397	CbGpPWpGaD
Bromodiphenhydramine—Promazine—DRD4—schizophrenia	0.00282	0.00999	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.00281	0.00392	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CHRM1—schizophrenia	0.00278	0.00987	CrCbGaD
Bromodiphenhydramine—Tolterodine—CYP2D6—schizophrenia	0.00278	0.00986	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CHRM1—schizophrenia	0.00277	0.00981	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—schizophrenia	0.00273	0.00381	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—FZD3—schizophrenia	0.00273	0.0038	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—OXT—schizophrenia	0.00267	0.00372	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—CYP2D6—schizophrenia	0.00265	0.00941	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC1A1—schizophrenia	0.00261	0.00363	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GRM2—schizophrenia	0.00257	0.00357	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—TAAR6—schizophrenia	0.00257	0.00357	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—NPS—schizophrenia	0.00253	0.00353	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—HTR2C—schizophrenia	0.00248	0.00346	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.00248	0.00346	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—ABCB1—schizophrenia	0.00244	0.0034	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—SLC6A4—schizophrenia	0.00243	0.0086	CrCbGaD
Bromodiphenhydramine—Toremifene—ABCB1—schizophrenia	0.0024	0.0085	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—schizophrenia	0.00239	0.00333	CbGpPWpGaD
Bromodiphenhydramine—Carbinoxamine—CYP2D6—schizophrenia	0.00239	0.00846	CrCbGaD
Bromodiphenhydramine—Promazine—DRD1—schizophrenia	0.00239	0.00845	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC17A7—schizophrenia	0.00238	0.00332	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.00236	0.00329	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—schizophrenia	0.00236	0.00328	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—NTS—schizophrenia	0.00232	0.00323	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—HTR2C—schizophrenia	0.0023	0.00814	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.00229	0.00319	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—schizophrenia	0.00227	0.00316	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—HTR7—schizophrenia	0.00226	0.00802	CrCbGaD
Bromodiphenhydramine—Tamoxifen—ESR1—schizophrenia	0.00225	0.00799	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR7—schizophrenia	0.00225	0.00797	CrCbGaD
Bromodiphenhydramine—Doxepin—HTR1A—schizophrenia	0.00223	0.0079	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—schizophrenia	0.00222	0.0031	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GRM3—schizophrenia	0.00218	0.00304	CbGpPWpGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—EP300—schizophrenia	0.00218	0.00304	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—HTR1B—schizophrenia	0.00218	0.00772	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR6—schizophrenia	0.00214	0.00298	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—GABRB2—schizophrenia	0.00211	0.00295	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—DRD3—schizophrenia	0.00211	0.00749	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.00211	0.00294	CbGpPWpGaD
Bromodiphenhydramine—Brompheniramine—CYP2D6—schizophrenia	0.00207	0.00733	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.00207	0.00288	CbGpPWpGaD
Bromodiphenhydramine—Promazine—HTR2C—schizophrenia	0.00204	0.00723	CrCbGaD
Bromodiphenhydramine—Chlorphenamine—CYP2D6—schizophrenia	0.00203	0.0072	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.00203	0.00282	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.00199	0.00277	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—SLC6A3—schizophrenia	0.00198	0.00702	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.00196	0.00274	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—APOA1—schizophrenia	0.00193	0.00268	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.00192	0.00268	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.00192	0.00268	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—SLC6A4—schizophrenia	0.0019	0.00674	CrCbGaD
Bromodiphenhydramine—Fluoxetine—ABCB1—schizophrenia	0.0019	0.00672	CrCbGaD
Bromodiphenhydramine—Doxepin—DRD2—schizophrenia	0.00189	0.00671	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CHRM1—schizophrenia	0.00189	0.00264	CbGpPWpGaD
Bromodiphenhydramine—Atomoxetine—HTR2A—schizophrenia	0.00187	0.00661	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.00186	0.00259	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00183	0.00256	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC18A2—schizophrenia	0.00183	0.00254	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DGKI—schizophrenia	0.00181	0.00253	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.00181	0.00252	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—HTR2C—schizophrenia	0.00179	0.00633	CrCbGaD
Bromodiphenhydramine—Diphenhydramine—CYP1A2—schizophrenia	0.00178	0.00633	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR2C—schizophrenia	0.00178	0.00629	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00177	0.00247	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00177	0.00247	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GRM5—schizophrenia	0.00176	0.00245	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—CYP1A2—schizophrenia	0.00174	0.00616	CrCbGaD
Bromodiphenhydramine—Imipramine—HTR1A—schizophrenia	0.00173	0.00615	CrCbGaD
Bromodiphenhydramine—Doxepin—CYP1A2—schizophrenia	0.00173	0.00614	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.00172	0.0024	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—HTR1A—schizophrenia	0.00172	0.00611	CrCbGaD
Bromodiphenhydramine—Atomoxetine—CYP2D6—schizophrenia	0.00171	0.00605	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.0017	0.00237	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.00168	0.00234	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.00168	0.00234	CbGpPWpGaD
Bromodiphenhydramine—Promazine—DRD2—schizophrenia	0.00168	0.00596	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC6A1—schizophrenia	0.00168	0.00234	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00168	0.00234	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DGKI—schizophrenia	0.00165	0.00229	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00165	0.00229	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00165	0.00229	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCK—schizophrenia	0.00161	0.00224	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00159	0.00222	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00155	0.00216	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CCKAR—schizophrenia	0.00154	0.00215	CbGpPWpGaD
Bromodiphenhydramine—Promazine—CYP1A2—schizophrenia	0.00154	0.00546	CrCbGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—HTR2A—schizophrenia	0.00152	0.00212	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PPP1R1B—schizophrenia	0.00151	0.0021	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ATP2A2—schizophrenia	0.0015	0.00209	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—ADORA2A—schizophrenia	0.0015	0.00208	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—SLC6A4—schizophrenia	0.00148	0.00525	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00148	0.00206	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—DRD2—schizophrenia	0.00147	0.00522	CrCbGaD
Bromodiphenhydramine—Amitriptyline—SLC6A4—schizophrenia	0.00147	0.00521	CrCbGaD
Bromodiphenhydramine—Amitriptyline—DRD2—schizophrenia	0.00146	0.00519	CrCbGaD
Bromodiphenhydramine—Doxepin—HTR2A—schizophrenia	0.00146	0.00518	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM2—schizophrenia	0.00145	0.00202	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—TAAR6—schizophrenia	0.00145	0.00202	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.00144	0.00201	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.00144	0.00201	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—FZD3—schizophrenia	0.0014	0.00195	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—NPY—schizophrenia	0.0014	0.00195	CbGpPWpGaD
Bromodiphenhydramine—Diphenhydramine—CYP2D6—schizophrenia	0.00138	0.00488	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.00136	0.0019	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—OXT—schizophrenia	0.00135	0.00188	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR1B—schizophrenia	0.00135	0.00188	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CYP1A2—schizophrenia	0.00135	0.00478	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—NGEF—schizophrenia	0.00134	0.00187	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—CYP2D6—schizophrenia	0.00134	0.00475	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CYP1A2—schizophrenia	0.00134	0.00475	CrCbGaD
Bromodiphenhydramine—Doxepin—CYP2D6—schizophrenia	0.00134	0.00474	CrCbGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—AKT1—schizophrenia	0.00132	0.00184	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PPP3CC—schizophrenia	0.00132	0.00183	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM2—schizophrenia	0.00132	0.00183	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—TAAR6—schizophrenia	0.00132	0.00183	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—NTS—schizophrenia	0.00131	0.00183	CbGpPWpGaD
Bromodiphenhydramine—Promazine—HTR2A—schizophrenia	0.0013	0.00461	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR1A—schizophrenia	0.0013	0.00181	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—NPS—schizophrenia	0.00128	0.00178	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD1—schizophrenia	0.00125	0.00175	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR2C—schizophrenia	0.00125	0.00175	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM3—schizophrenia	0.00123	0.00172	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—RGS4—schizophrenia	0.00123	0.00172	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—NGEF—schizophrenia	0.00122	0.0017	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD3—schizophrenia	0.00121	0.00169	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR6—schizophrenia	0.00121	0.00169	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC6A3—schizophrenia	0.0012	0.00167	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—NTS—schizophrenia	0.00119	0.00166	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.00118	0.00164	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD4—schizophrenia	0.00118	0.00164	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—HTR2A—schizophrenia	0.00114	0.00403	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR2A—schizophrenia	0.00113	0.00401	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—CNR1—schizophrenia	0.00113	0.00157	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—RGS4—schizophrenia	0.00112	0.00156	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM3—schizophrenia	0.00112	0.00156	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR6—schizophrenia	0.0011	0.00153	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD2—schizophrenia	0.0011	0.00153	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR7—schizophrenia	0.0011	0.00153	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CHRM1—schizophrenia	0.00107	0.00149	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—IL3RA—schizophrenia	0.00104	0.00145	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—CYP2D6—schizophrenia	0.00104	0.00369	CrCbGaD
Bromodiphenhydramine—Amitriptyline—CYP2D6—schizophrenia	0.00103	0.00366	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.00101	0.00141	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM5—schizophrenia	0.000994	0.00138	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DGKI—schizophrenia	0.000973	0.00136	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CHRM1—schizophrenia	0.000971	0.00135	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—ABCB1—schizophrenia	0.000959	0.00134	CbGpPWpGaD
Bromodiphenhydramine—Tamoxifen—ABCB1—schizophrenia	0.000958	0.00339	CrCbGaD
Bromodiphenhydramine—Doxepin—ABCB1—schizophrenia	0.000955	0.00338	CrCbGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—IL3RA—schizophrenia	0.000946	0.00132	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCK—schizophrenia	0.000909	0.00127	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM5—schizophrenia	0.000903	0.00126	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PPP1R1B—schizophrenia	0.00089	0.00124	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—PDE4B—schizophrenia	0.000886	0.00123	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CCKAR—schizophrenia	0.000872	0.00121	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADORA2A—schizophrenia	0.000845	0.00118	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FZD3—schizophrenia	0.000827	0.00115	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCK—schizophrenia	0.000826	0.00115	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PDE4B—schizophrenia	0.000804	0.00112	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CCKAR—schizophrenia	0.000791	0.0011	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—NPY—schizophrenia	0.00079	0.0011	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PPP3CC—schizophrenia	0.000778	0.00108	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM2—schizophrenia	0.000778	0.00108	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FES—schizophrenia	0.000778	0.00108	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TAAR6—schizophrenia	0.000778	0.00108	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR2A—schizophrenia	0.000769	0.00107	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADORA2A—schizophrenia	0.000767	0.00107	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR1B—schizophrenia	0.000762	0.00106	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—OXT—schizophrenia	0.000762	0.00106	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—APOA1—schizophrenia	0.000757	0.00105	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—ABCB1—schizophrenia	0.000743	0.00263	CrCbGaD
Bromodiphenhydramine—Amitriptyline—ABCB1—schizophrenia	0.000738	0.00262	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR1A—schizophrenia	0.000733	0.00102	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—NPS—schizophrenia	0.000722	0.00101	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NGEF—schizophrenia	0.00072	0.001	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—NPY—schizophrenia	0.000717	0.000999	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR2C—schizophrenia	0.000708	0.000987	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD1—schizophrenia	0.000708	0.000987	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NTS—schizophrenia	0.000704	0.00098	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR1B—schizophrenia	0.000692	0.000964	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—OXT—schizophrenia	0.000692	0.000964	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD3—schizophrenia	0.000686	0.000955	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR1A—schizophrenia	0.000666	0.000928	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD4—schizophrenia	0.000666	0.000928	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM3—schizophrenia	0.000661	0.000921	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RGS4—schizophrenia	0.000661	0.000921	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RTN4—schizophrenia	0.000661	0.000921	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—NPS—schizophrenia	0.000656	0.000914	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR6—schizophrenia	0.000649	0.000904	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR2C—schizophrenia	0.000643	0.000896	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD1—schizophrenia	0.000643	0.000896	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—CNR1—schizophrenia	0.000636	0.000886	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MAG—schizophrenia	0.000627	0.000874	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD3—schizophrenia	0.000623	0.000868	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR7—schizophrenia	0.00062	0.000864	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD2—schizophrenia	0.00062	0.000864	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD4—schizophrenia	0.000605	0.000842	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—CNR1—schizophrenia	0.000577	0.000804	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CHRM1—schizophrenia	0.000574	0.000799	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR7—schizophrenia	0.000563	0.000785	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD2—schizophrenia	0.000563	0.000785	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—IL3RA—schizophrenia	0.000559	0.000779	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NRG3—schizophrenia	0.000546	0.00076	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TLE1—schizophrenia	0.000546	0.00076	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GFAP—schizophrenia	0.000539	0.000751	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM5—schizophrenia	0.000533	0.000743	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TLE3—schizophrenia	0.000516	0.000719	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCK—schizophrenia	0.000488	0.000679	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PDE4B—schizophrenia	0.000475	0.000662	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CCKAR—schizophrenia	0.000468	0.000651	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADORA2A—schizophrenia	0.000453	0.000632	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—PLA2G4A—schizophrenia	0.000446	0.000621	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—FGA—schizophrenia	0.000435	0.000605	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR2A—schizophrenia	0.000434	0.000605	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NPY—schizophrenia	0.000424	0.00059	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NOTCH4—schizophrenia	0.000424	0.00059	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ATP2A2—schizophrenia	0.000424	0.00059	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR1B—schizophrenia	0.000409	0.000569	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—OXT—schizophrenia	0.000409	0.000569	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR2A—schizophrenia	0.000395	0.00055	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR1A—schizophrenia	0.000393	0.000548	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NPS—schizophrenia	0.000387	0.00054	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD1—schizophrenia	0.00038	0.000529	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR2C—schizophrenia	0.00038	0.000529	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NTRK2—schizophrenia	0.00037	0.000515	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD3—schizophrenia	0.000368	0.000513	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD4—schizophrenia	0.000357	0.000498	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—CNR1—schizophrenia	0.000341	0.000475	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD2—schizophrenia	0.000333	0.000464	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR7—schizophrenia	0.000333	0.000464	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PRL—schizophrenia	0.000314	0.000438	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—S100B—schizophrenia	0.000293	0.000408	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ERBB4—schizophrenia	0.00028	0.00039	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—PLA2G4A—schizophrenia	0.000263	0.000367	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—NRG1—schizophrenia	0.000258	0.00036	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—MEF2C—schizophrenia	0.000256	0.000357	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—YWHAZ—schizophrenia	0.000248	0.000345	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ERBB3—schizophrenia	0.000242	0.000337	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR2A—schizophrenia	0.000233	0.000325	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOE—schizophrenia	0.000217	0.000302	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—APOA1—schizophrenia	0.000214	0.000298	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ESR1—schizophrenia	0.000207	0.000288	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GSK3B—schizophrenia	0.000188	0.000261	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—AKT1—schizophrenia	0.000139	0.000194	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—AKT1—schizophrenia	0.000126	0.000176	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EP300—schizophrenia	0.000123	0.000172	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—TP53—schizophrenia	8.84e-05	0.000123	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—AKT1—schizophrenia	7.46e-05	0.000104	CbGpPWpGaD
